Details for New Drug Application (NDA): 089649
✉ Email this page to a colleague
NDA 089649 describes LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, which is a drug marketed by B Braun Medical Inc, Belmora Llc, Eastman Kodak, Hospira, West-ward Pharms Int, and Empi, and is included in fourteen NDAs. It is available from five suppliers. Additional details are available on the LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE profile page.
The generic ingredient in LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
The generic ingredient in LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Summary for 089649
| Tradename: | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE |
| Applicant: | Hospira |
| Ingredient: | epinephrine; lidocaine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.005MG/ML;1% | ||||
| Approval Date: | Jun 21, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
